Herb-induced liver injury in the berlin case-control surveillance study

International Journal of Molecular Sciences

Volumn 17, Issue 1, 2016, Pages

  Douros, Antonios ^a   Bronder, Elisabeth ^a   Andersohn, Frank ^a   Klimpel, Andreas ^a   Kreutz, Reinhold ^a   Garbe, Edeltraut ^a,b   Bolbrinker, Juliane ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

Author keywords

Hepatotoxicity; Pharmacovigilance; Phytotherapeutics

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CORTICOSTEROID; LEAD; METOPROLOL; PLANT MEDICINAL PRODUCT;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CHOLESTASIS; CLINICAL ARTICLE; EUCALYPTUS GLOBULUS; FATIGUE; FEMALE; GERMANY; HERB; HERBAL TEA; HUMAN; HYPERBILIRUBINEMIA; HYPERICUM PERFORATUM; INFLAMMATION; JAUNDICE; LIVER INJURY; LIVER NECROSIS; MALE; MENTHA PIPERITA; MIDDLE AGED; PELARGONIUM; RASH; VALERIANA; AGED; CASE CONTROL STUDY; CHEMICAL AND DRUG INDUCED LIVER INJURY;

ADULT; AGED; CASE-CONTROL STUDIES; CHEMICAL AND DRUG INDUCED LIVER INJURY; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PLANT PREPARATIONS;

EID: 84954307196     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17010114     Document Type: Article

References (39)

1. Stickel, F.; Shouval, D. Hepatotoxicity of herbal and dietary supplements: An update. Arch. Toxicol. 2015, 89, 851-865. [CrossRef] [PubMed]
2. Navarro, V.J. Herbal and dietary supplement hepatotoxicity. Semin. Liver Dis. 2009, 29, 373-382. [CrossRef] [PubMed]
3. Navarro, V.J.; Barnhart, H.; Bonkovsky, H.L.; Davern, T.; Fontana, R.J.; Grant, L.; Reddy, K.R.; Seeff, L.B.; Serrano, J.; Sherker, A.H.; et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 2014, 60, 1399-1408. [CrossRef] [PubMed]
4. Teschke, R.;Wolff, A.; Frenzel, C.; Schulze, J.; Eickhoff, A. Herbal hepatotoxicity: A tabular compilation of reported cases. Liver Int. 2012, 32, 1543-1556. [CrossRef] [PubMed]
5. Calitz, C.; du Plessis, L.; Gouws, C.; Steyn, D.; Steenekamp, J.; Muller, C.; Hamman, S. Herbal hepatotoxicity: Current status, examples, and challenges. Expert Opin. Drug Metab. Toxicol. 2015, 11, 1551-1565. [CrossRef] [PubMed]
6. Geller, A.I.; Shehab, N.;Weidle, N.J.; Lovegrove, M.C.;Wolpert, B.J.; Timbo, B.B.; Mozersky, R.P.; Budnitz, D.S. Emergency department visits for adverse events related to dietary supplements. N. Engl. J. Med. 2015, 373, 1531-1540. [CrossRef] [PubMed]
7. Douros, A.; Bronder, E.; Andersohn, F.; Klimpel, A.; Thomae, M.; Sarganas, G.; Kreutz, R.; Garbe, E. Drug-induced liver injury: Results from the hospital-based Berlin Case-Control Surveillance Study. Br. J. Clin. Pharmacol. 2015, 79, 988-999. [CrossRef] [PubMed]
8. Wu, C.H.; Wang, C.C.; Kennedy, J. Changes in herb and dietary supplement use in the U.S. adult population: A comparison of the 2002 and 2007 National Health Interview Surveys. Clin. Ther. 2011, 33, 1749-1758. [CrossRef] [PubMed]
9. Dantuluri, S.; North-Lewis, P.; Karthik, S.V. Gotu Kola induced hepatotoxicity in a child-need for caution with alternative remedies. Dig. Liver Dis. 2011, 43. [CrossRef] [PubMed]
10. Jorge, O.A.; Jorge, A.D. Hepatotoxicity associated with the ingestion of Centella asiatica. Rev. Esp. Enferm. Dig. 2005, 97, 115-124. [CrossRef] [PubMed]
11. Teschke, R.; Bahre, R. Severe hepatotoxicity by Indian Ayurvedic herbal products: A structured causality assessment. Ann. Hepatol. 2009, 8, 258-266. [PubMed]
12. AkdÄ Hepatitis im Zusammenhang mit Umckaloabo®. Available online: http://www.akdae.de/ Arzneimittelsicherheit/Bekanntgaben/Archiv/2011/20110729.html (accessed on 7 October 2015).
13. Teschke, R.; Frenzel, C.; Schulze, J.; Eickhoff, A. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained? Regul. Toxicol. Pharmacol. 2012, 63, 1-9. [CrossRef] [PubMed]
14. Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Pelargonium sidoides DC and/or Pelargonium reniforme Curt., radix. Available online: http://www.ema.europa.eu/ docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2013/02/WC500138439.pdf (accessed on 7 October 2015).
15. BfArM. Abwehr von Gefahren durch Arzneimittel, Stufe II: Pelargonium-Wurzel-Haltige Arzneimittel. Available online: http://www.abda.de/fileadmin/assets/Arzneimittelkommission/PDF/Sonstiges_Anhaenge_ fuer_Nachrichten/14_14_Info_Bescheid_Pelagoniumhaltige_Arzneimittel_BfArM.pdf (accessed on 17 October 2015).
16. Timmer, A.; Gunther, J.; Motschall, E.; Rucker, G.; Antes, G.; Kern, W.V. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst. Rev. 2013, 10, Cd006323. [PubMed]
17. Cohen, D.L.; del Toro, Y. A case of valerian-associated hepatotoxicity. J. Clin. Gastroenterol. 2008, 42, 961-962. [CrossRef] [PubMed]
18. MacGregor, F.B.; Abernethy, V.E.; Dahabra, S.; Cobden, I.; Hayes, P.C. Hepatotoxicity of herbal remedies. BMJ 1989, 299, 1156-1157. [CrossRef] [PubMed]
19. Mennecier, D.; Saloum, T.; Dourthe, P.M.; Bronstein, J.A.; Thiolet, C.; Farret, O. Acute hepatitis after phytotherapy. Presse Med. 1999, 28, 966. [PubMed]
20. Vassiliadis, T.; Anagnostis, P.; Patsiaoura, K.; Giouleme, O.; Katsinelos, P.; Mpoumponaris, A.; Eugenidis, N. Valeriana hepatotoxicity. Sleep Med. 2009, 10. [CrossRef] [PubMed]
21. LIVERTOX®. VALERIAN (VALERIANA OFFICINALIS). Available online: http://livertox.nih.gov/ Valerian.htm (accessed on 18 December 2015).
22. Etogo-Asse, F.; Boemer, F.; Sempoux, C.; Geubel, A. Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort). Case of drug interaction? Acta Gastroenterol. Belg. 2008, 71, 36-38. [PubMed]
23. Piccolo, P.; Gentile, S.; Alegiani, F.; Angelico, M. Severe drug induced acute hepatitis associated with use of St John's wort (Hypericum perforatum) during treatment with pegylated interferon alpha. BMJ Case Rep. 2009. [CrossRef] [PubMed]
24. Promethazine-Summary of Product Characteristics. Available online: http://www.medicines.org.uk/ emc/medicine/15313/SPC/Phenergan+Elixir (accessed on 13 October 2015).
25. Vo, L.T.; Chan, D.; King, R.G. Investigation of the effects of peppermint oil and valerian on rat liver and cultured human liver cells. Clin. Exp. Pharmacol. Physiol. 2003, 30, 799-804. [CrossRef] [PubMed]
26. Anderson, I.B.; Mullen, W.H.; Meeker, J.E.; Khojasteh Bakht, S.C.; Oishi, S.; Nelson, S.D.; Blanc, P.D. Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature. Ann. Intern. Med. 1996, 124, 726-734. [CrossRef] [PubMed]
27. Bakerink, J.A.; Gospe, S.M., Jr.; Dimand, R.J.; Eldridge, M.W. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics 1996, 98, 944-947. [PubMed]
28. Sullivan, J.B., Jr.; Rumack, B.H.; Thomas, H., Jr.; Peterson, R.G.; Bryson, P. Pennyroyal oil poisoning and hepatotoxicity. JAMA 1979, 242, 2873-2874. [CrossRef] [PubMed]
29. Vallance, W.B. Pennyroyal poisoning: A fatal case. Lancet 1955, 269, 850-851. [CrossRef]
30. Yuen, M.F.; Tam, S.; Fung, J.; Wong, D.K.; Wong, B.C.; Lai, C.L. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: A 1-year prospective study. Aliment. Pharmacol. Ther. 2006, 24, 1179-1186. [CrossRef] [PubMed]
31. Kim, N.H.; Hyun, S.H.; Jin, C.H.; Lee, S.K.; Lee, D.W.; Jeon, T.W.; Lee, J.S.; Chun, Y.J.; Lee, E.S.; Jeong, T.C. Pretreatment with 1,8-cineole potentiates thioacetamide-induced hepatotoxicity and immunosuppression. Arch. Pharm. Res. 2004, 27, 781-789. [CrossRef] [PubMed]
32. Xu, J.; Hu, Z.Q.; Wang, C.; Yin, Z.Q.; Wei, Q.; Zhou, L.J.; Li, L.; Du, Y.H.; Jia, R.Y.; Li, M.; et al. Acute and subacute toxicity study of 1,8-cineole in mice. Int. J. Clin. Exp. Pathol. 2014, 7, 1495-1501. [PubMed]
33. Davern, T.J.; Chalasani, N.; Fontana, R.J.; Hayashi, P.H.; Protiva, P.; Kleiner, D.E.; Engle, R.E.; Nguyen, H.; Emerson, S.U.; Purcell, R.H.; et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011, 141, 1665-16672.e9. [CrossRef] [PubMed]
34. Teschke, R.; Frenzel, C.; Wolff, A.; Eickhoff, A.; Schulze, J. Drug induced liver injury: Accuracy of diagnosis in published reports. Ann. Hepatol. 2014, 13, 248-255. [PubMed]
35. Stammschulte, T.; Gundert-Remy, U. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained? Regul. Toxicol. Pharmacol. 2012, 64, author reply. 343-344. [CrossRef] [PubMed]
36. Douros, A.; Bronder, E.; Andersohn, F.; Klimpel, A.; Thomae, M.; Ockenga, J.; Kreutz, R.; Garbe, E. Drug-induced acute pancreatitis: Results from the hospital-based Berlin case-control surveillance study of 102 cases. Aliment. Pharmacol. Ther. 2013, 38, 825-834. [CrossRef] [PubMed]
37. Garbe, E.; Andersohn, F.; Bronder, E.; Klimpel, A.; Thomae, M.; Schrezenmeier, H.; Hildebrandt, M.; Spath-Schwalbe, E.; Gruneisen, A.; Mayer, B.; et al. Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. Br. J. Haematol. 2011, 154, 644-653. [CrossRef] [PubMed]
38. Benichou, C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J. Hepatol. 1990, 11, 272-276. [PubMed]
39. Teschke, R.; Wolff, A.; Frenzel, C.; Schwarzenboeck, A.; Schulze, J.; Eickhoff, A. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment. World J. Hepatol. 2014, 6, 17-32. [PubMed]